Home Cart 0 Sign in  
X

[ CAS No. 50270-27-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 50270-27-4
Chemical Structure| 50270-27-4
Chemical Structure| 50270-27-4
Structure of 50270-27-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 50270-27-4 ]

Related Doc. of [ 50270-27-4 ]

Alternatived Products of [ 50270-27-4 ]
Product Citations

Product Details of [ 50270-27-4 ]

CAS No. :50270-27-4 MDL No. :MFCD02257700
Formula : C5HCl3N2O Boiling Point : -
Linear Structure Formula :- InChI Key :KVJIRFGNHAAUNQ-UHFFFAOYSA-N
M.W : 211.43 Pubchem ID :10932746
Synonyms :

Calculated chemistry of [ 50270-27-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.45
TPSA : 42.85 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.78 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.34
Log Po/w (XLOGP3) : 2.55
Log Po/w (WLOGP) : 2.25
Log Po/w (MLOGP) : 0.79
Log Po/w (SILICOS-IT) : 3.05
Consensus Log Po/w : 2.0

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.1
Solubility : 0.17 mg/ml ; 0.000803 mol/l
Class : Soluble
Log S (Ali) : -3.1
Solubility : 0.169 mg/ml ; 0.000799 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.46
Solubility : 0.074 mg/ml ; 0.00035 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.61

Safety of [ 50270-27-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Applications of [ 50270-27-4 ]

2,4,6-Trichloropyrimidine-5-carboxaldehyde (CAS: 50270-27-4) is an aniline derivative. It has been shown to inhibit nucleophilic substitutions involving flavin and metal ions.

Application In Synthesis of [ 50270-27-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 50270-27-4 ]
  • Downstream synthetic route of [ 50270-27-4 ]

[ 50270-27-4 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 50270-27-4 ]
  • [ 42754-96-1 ]
YieldReaction ConditionsOperation in experiment
67% With triethylamine; hydrazine In methanol at -10℃; for 2 h; (2)
To a solution of the compound obtained in the above step (1) (40 g) in methanol (950 mL) was added dropwise a solution of hydrazine monohydrate (9.45 mL) in methanol (240 mL) at -10 °C and thereto was added dropwise a solution of triethylamine (26.8 mL) in methanol (240 mL) at -10 °C.
The mixture was stirred at the same temperature for 2 hours and evaporated in vacuo.
The residue was suspended in hot isopropyl alcohol and the insoluble materials were removed by filtration.
The combined filtrate was concentrated in vacuo to give 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine (23.49 g, yield: 67 percent) as a yellow amorphous solid.
MS(APCI)m/z; Not detectable.
66.8% With hydrazine hydrate; triethylamine In methanol at -10℃; Step 2: To a solution of 1f (38.0g, 0.18mol, 1eq) in methanol (700mL) was added drop-wise a solution of hydrazine monohydrate (9.2mL) in methanol (180mL) at -100C and thereto was added drop-wise a solution of triethylamine (25.5mL) in methanol (180mL) at -100C. The mixture was stirred at the same temperature for 30min, the solvent was removed and the residue was purified by column chromatography to afford 7b (22.7g, yield: 66.8percent) as a light yellow solid. 1H NMR(CDCl3, 300MHz, ppm): δ=11.25(s, 1H), 8.23(s, 1H).
62% With hydrazine hydrate; triethylamine In methanol at 0℃; for 0.5 h; To a solution of 2,4,6-trichloropyrimidine-5-carbaldehyde (19.0 g, 990 mmol) in methanol (300 mL) was added drop-wise a solution of hydrazine monohydrate (4.8 mL) in methanol (80 mL) at 0 °C followed by drop-wise addition of triethylamine (13 mL) in methanol (80 mL) at 0 °C. The mixture was stirred at the same temperature for 30 mm. The solvent was removed and the residue was purified by flash chromatography to afford the title compound (10.3 g, 62percent yield) as a yellow solid. ‘H NMR (CDC13, 400IVIHz): 11.56 (br, 1H), 8.43 (s, 1H). MS m/z 190.68 [M+1].
56.3% With hydrazine hydrate; triethylamine In methanol at -10℃; for 0.5 h; At -10 willCompound 3 (100 mg, 0.47 mmol)In methanol was slowly added dropwise to a methanolic solution of hydrazine hydrate (0.024 ml)A solution of triethylamine (0.067 ml) in methanol was then added dropwiseTo the above mixture,Continue at -10 Reaction time 30 min.TLC detection (PE: EA = 2: 1),Raw material reaction is complete,Spin drying solvent,Column chromatography (PE: EA = 10: 1) gaveWhite solid 4 (50 mg), yield 56.3percent
40% With hydrazine hydrate; triethylamine In tetrahydrofuran at -10℃; for 0.5 h; To a solution of 2,4,6-trichloropyrimidine-5-carbaldehyde (3.50 g, 16.6 mmol) in THF (50 mL)was added N2H4.H20 (830 mg, 16.6 mmol) slowly at-lO °C. Then, Et3N (2.51 g, 24.9 mmol)was added to the mixture at -10 00. The mixture was stirred at -10 °C for 30 mm. The mixture was concentrated. The residue was purified by column chromatography (petroleum ether: ethyl acetate = 10: 1) to give the title compound (1.25 g, yield 40percent) as a yellow solid. 1H NMR (300 MHz, CDCI3): 611.61 (brs, 1H), 8.25 (s, IH).LCMS [mobile phase: 5-95percent CH3CNJ: Rt = 2.005 mm;MS Calcd: 188; MS Found: 189 [M+H].

Reference: [1] Patent: EP1772454, 2007, A1, . Location in patent: Page/Page column 58
[2] Patent: WO2010/56320, 2010, A2, . Location in patent: Page/Page column 60
[3] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 5, p. 584 - 589
[4] Patent: WO2016/130920, 2016, A2, . Location in patent: Page/Page column 119
[5] Patent: , 2016, , . Location in patent: Paragraph 0019
[6] Patent: WO2017/12576, 2017, A1, . Location in patent: Page/Page column 197
[7] Patent: US2009/162319, 2009, A1, . Location in patent: Page/Page column 139
  • 2
  • [ 50270-27-4 ]
  • [ 302-01-2 ]
  • [ 42754-96-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 24, p. 6830 - 6835
  • 3
  • [ 60-34-4 ]
  • [ 50270-27-4 ]
  • [ 98141-42-5 ]
YieldReaction ConditionsOperation in experiment
78% With triethylamine In ethanol; water at -78 - 0℃; for 2.5 h; To a solution of 2,4,6-trichloropyrimidine-5-carbaldehyde (8 g, 37.84 mmol, 1.00 equiv) in ethanol (120 mL) was added a 40percent water solution of methylhydrazine (4 mL, 37.98 mmol, 1.00 equiv) and triethylamine (16 mL) at -78° C.
The resulting mixture was stirred for 30 min at -78° C. and then 2 h at 0° C.
After completion the reaction was concentrated under vacuum without heating.
Then ethyl acetate was added and the solution was washed with saturated ammonium chloride solution.
The organic layer was dried over anhydrous sodium sulfate and concentrated under vacuum without heating.
The residue was purified by silica gel column chromatography eluting with ethyl acetate/petroleum ether (1:1) to afford 6 g (78percent) of 4,6-dichloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine as a white solid. LC-MS (ES, m/z): 203 [M+H]+.
78% With triethylamine In ethanol; water at -78 - 0℃; for 2.5 h; To a solution of 2,4,6-trichloropyrimidine-5-carbaldehyde (8 g, 37.84 mmol, 1.00 equiv) in ethanol (120 mL) was added a 40percent water solution of methylhydrazine (4 mL, 37.98 mmol, 1.00equiv) and triethylamine (16 mL) at -78 °C. The resulting mixture was stuffed for 30 mm at -78 °C and then 2h at 0 °C. After completion the reaction was concentrated under vacuum without heating. Then ethyl acetate was added and the solution was washed with saturated ammonium chloride solution. The organic layer was dried over anhydrous sodium sulfate and concentrated under vacuum without heating. The residue was purified by silica gel column chromatography eluting with ethyl acetate/petroleum ether (1:1) to afford 6 g (78percent) of4,6-dichloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine as a white solid. LC-MS (ES, m/z): 203 [M+H] .
44.9% With triethylamine In ethanol; water at -70 - 0℃; for 2.5 h; To a stirred solution of 2 4 6-trichloropyrimidine-5-carbaldehyde (18.5 g 88.1 mmol) in EtOH (250 mL) was added methyl hydrazine (6.8 g 88.1 mmol 60in water) and Et3N (26.7 g 264.4 mmol) at-70 and stirred for 30 min before it was allowed to warm up to 0 and stirred for another 2 h. After TLC (petroleum etherEtOAc 51) showed that the reaction was completed the mixture solution was concentrated in vacuo at room temperature. EtOAc (200 mL) was added and the resulting solution was washed washed with saturated aqueous NaHCO3solution and brine. The organic layer was dried over anhydrous Na2SO4 filtered and concentrated in vaouoto give a crude product which was purified by silica gel flash chomatography (petroleum etherEtOAc 201) to afford title compound (8 g 44.9yield) as a white solid. MS 203.2 [M+H]+.
Reference: [1] Patent: US2015/57260, 2015, A1, . Location in patent: Paragraph 0414; 0415
[2] Patent: WO2015/25026, 2015, A1, . Location in patent: Page/Page column 114
[3] Patent: WO2017/133664, 2017, A1, . Location in patent: Page/Page column 83
[4] Patent: US2008/234262, 2008, A1, . Location in patent: Page/Page column 83-84
[5] Patent: US2009/98086, 2009, A1, . Location in patent: Page/Page column 59
[6] Patent: US2010/15141, 2010, A1, . Location in patent: Page/Page column 17
[7] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 4, p. 1440 - 1444
[8] Patent: US2012/208808, 2012, A1, . Location in patent: Page/Page column 17-18
  • 4
  • [ 68-12-2 ]
  • [ 67-52-7 ]
  • [ 50270-27-4 ]
YieldReaction ConditionsOperation in experiment
47%
Stage #1: for 15 h; Reflux
Stage #2: With sodium hydrogencarbonate In water; ethyl acetate
Intermediate M(l)A solution of pyrimidine-2,4,6-triol (10.0 g, 78.2 mmol), DMF (12 mL) in POCl3 (10 vol.) was heated at reflux for 15 h. The excess of POCI3 was evaporated under reduced pressure. The residue was poured in to crushed ice. The precipitated solid was filtered and washed with water to give 2,4,6-trichloropyrimidine-5-carbaldehyde (8.0 g, 47percent) as yellow solid. This compound was taken to the next step without further purification.
36% Reflux A mixture of pyrimidine-2,4,6-triol (20.0 g, 156 mmol) in DMF (20 mL) and POCI3 (200 mL)was refluxed overnight. The mixture was concentrated. The residue was poured into ice-water (1 L) and filtered. The solid was collected and purified by column chromatography (petroleum ether: ethyl acetate = 10: 1)to give the title compound (12.0 g, yield 36percent) as a yellow solid.1H NMR (CDCI3, 300 MHz): 6 10.41 (s, 1H).
Reference: [1] Angewandte Chemie - International Edition, 2006, vol. 45, # 43, p. 7262 - 7265
[2] Patent: WO2012/103297, 2012, A1, . Location in patent: Page/Page column 84-85
[3] Patent: WO2017/12576, 2017, A1, . Location in patent: Page/Page column 197
[4] Patent: WO2011/14535, 2011, A1, . Location in patent: Page/Page column 100
[5] Patent: WO2004/18435, 2004, A1, . Location in patent: Page 55-56
  • 5
  • [ 67-52-7 ]
  • [ 68-12-2 ]
  • [ 50270-27-4 ]
YieldReaction ConditionsOperation in experiment
88% at 120℃; for 15 h; A mixture of barbituric acid (5 g, 78.1 mmol) in POCl3 (47 mL) and DMF (6 mL) was heated at 1200C for 15 h; and then evaporated in vacuo to give a thick oily residue. To the residue at 0 0C, was added icy water to give a yellow precipitate. The precipitate was collected by vacuum filtration and was rinsed with water to give Compound 7A (14.45 g, 88percent). 1H NMR (CD3Cl) δ 11.45 (s, IH).
77.2% at 120℃; for 16 h; Step 1: DMF (24mL) was added drop-wise to POCl3 (150mL, 1.61mol, 6.9eq) at a temperature below 00C and barbituric acid(30.0g, 234mmol, 1eq) was added portion- wise to the mixture. The mixture was stirred at 120 0C for 16h. Excess amount of POCl3 was removed in vacuo and the resulting residue was gradually poured to ice water. The mixture was extracted with DCM (100mL) three times, the organic layer was washed with sat. NaHCO3 solution, dried and concentrated to give 1f (38.0g, yield: 77.2percent) as a yellow solid. 1H NMR(CDCl3, 300MHz, ppm): δ=10.41 (s, 1H).
75% at -2 - 120℃; for 22 h; To a 25 ml dry two neck flask34.6 ml of POCl was added,Cooled in a low temperature cooling tank at -2 ° C,0.6 ml of dry DMF was added dropwise,Compound 2 (1 g, 7.8 mmol) was added portionwise,The reaction was carried out at 120 ° C for 22 h,TLC detection (DCM: MeOH = 10: 1), The basic reaction of raw materials completely,The reaction solution was slowly poured into ice water,A yellow solid precipitation,Filtration gave a tan solid,EA extract filtrate,concentrate,Combine the column chromatography (PE: EA = 200: 1) to give white solid 3 (1.2 mg)Yield 75percent.
74%
Stage #1: at 10 - 90℃; for 26 h;
2,4,6-Trichloropyrimidine-5-carbaldehydeDry DMF (33 ml) was added drop-wise to a cooled (10-15 0C) phosphorus oxychloride (315 ml). Then barbituric acid (45 g) was added at once upon effective stirring. The suspension was left overnight at room temperature after which it was heated at 50 0C for 6 h and at 90 0C for 20 h. Remainder OfPOCl3 was evaporated and the residue was poured on crushed ice (700 g) and water (400 ml). Light yellow precipitate was filtered, the solid washed with water, and dried. Crude product was dissolved in dichloromethane (500 ml) and an insoluble material was filtered off. Evaporation of solvent afforded 57.4 g (74percent) of 2,4,6-trichloropyrimidine-5- carbaldehyde , m.p. 129-130 0C.
70%
Stage #1: at 10℃; for 0.333333 h;
Stage #2: at 10 - 90℃;
(1)
N,N-Dimethylformamide (39.3 mL) was added dropwise to phosphorus oxychloride (250 mL) at a temperature bellow 10 °C and thereto was added portionwise barbituric acid (50 g) over a period of 20 minutes and the mixture was stirred at room temperature and then stirred at 90 °C overnight.
The reaction mixture was evaporated to remove excess amount of phosphorus oxychloride.
The resultant residue was gradually poured to water under stirring.
The mixture was extracted with chloroform and the organic layer was dried over sodium sulfate and concentrated in vacuo.
The resultant precipitates were triturated in isopropylether and collected by filtration to give 5-formyl-2,4,6-trichloropyrimidine (57.5 g, yield: 70 percent) as yellow crystals.
MS(APCI)m/z; Not detectable.

Reference: [1] Chemical Communications, 2010, vol. 46, # 35, p. 6527 - 6529
[2] Journal of the American Chemical Society, 2010, vol. 132, # 43, p. 15136 - 15139
[3] Patent: WO2008/39359, 2008, A2, . Location in patent: Page/Page column 38
[4] Patent: WO2010/56320, 2010, A2, . Location in patent: Page/Page column 59; 60
[5] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 5, p. 584 - 589
[6] Patent: , 2016, , . Location in patent: Paragraph 0019
[7] Patent: WO2006/128954, 2006, A1, . Location in patent: Page/Page column 8
[8] Journal of Labelled Compounds and Radiopharmaceuticals, 2014, vol. 57, # 13, p. 705 - 709
[9] Patent: EP1772454, 2007, A1, . Location in patent: Page/Page column 58
[10] MedChemComm, 2017, vol. 8, # 3, p. 640 - 646
[11] Journal of the American Chemical Society, 2001, vol. 123, # 16, p. 3854 - 3855
[12] Organic and Biomolecular Chemistry, 2015, vol. 13, # 18, p. 5082 - 5085
[13] Journal of Organic Chemistry, 2008, vol. 73, # 11, p. 4248 - 4251
[14] Journal of Medicinal Chemistry, 2009, vol. 52, # 22, p. 7081 - 7089
[15] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 2, p. 636 - 639
[16] Helvetica Chimica Acta, 2006, vol. 89, # 12, p. 2987 - 3001
[17] Journal of Organic Chemistry, 2013, vol. 78, # 21, p. 10666 - 10677
[18] Patent: US2008/234262, 2008, A1, . Location in patent: Page/Page column 50; 83
[19] Patent: US2009/98086, 2009, A1, . Location in patent: Page/Page column 58-59
[20] Patent: US2009/162319, 2009, A1, . Location in patent: Page/Page column 139
[21] Patent: US2010/15141, 2010, A1, . Location in patent: Page/Page column 17
[22] Journal of Medicinal Chemistry, 2009, vol. 52, # 24, p. 8010 - 8024
[23] Patent: US2012/208808, 2012, A1, . Location in patent: Page/Page column 17
[24] Patent: WO2016/130920, 2016, A2, . Location in patent: Page/Page column 118; 119
[25] ACS Chemical Neuroscience, 2017, vol. 8, # 11, p. 2522 - 2534
  • 6
  • [ 67-52-7 ]
  • [ 50270-27-4 ]
Reference: [1] Soft Matter, 2015, vol. 11, # 10, p. 1945 - 1953
[2] Patent: US2016/99415, 2016, A1,
  • 7
  • [ 67-52-7 ]
  • [ 28509-24-2 ]
  • [ 50270-27-4 ]
Reference: [1] Patent: US2003/60466, 2003, A1,
  • 8
  • [ 624-80-6 ]
  • [ 50270-27-4 ]
  • [ 864292-48-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 24, p. 6830 - 6835
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 4, p. 1440 - 1444
Recommend Products
Same Skeleton Products

Technical Information

• 1,4-Addition of an Amine to a Conjugated Enone • 1,4-Addition of an Amine to a Conjugated Enone • 1,4-Additions of Organometallic Reagents • Acetal Formation • Acid-Catalyzed α -Halogenation of Ketones • Add Hydrogen Cyanide to Aldehydes and Ketones to Produce Alcohols • Addition of a Hydrogen Halide to an Internal Alkyne • Alcohol Syntheses from Aldehydes, Ketones and Organometallics • Alcohols from Haloalkanes by Acetate Substitution-Hydrolysis • Aldehydes and Ketones Form Hemiacetals Reversibly • Aldehydes May Made by Terminal Alkynes Though Hydroboration-oxidation • Aldol Addition • Aldol Condensation • Alkenes React with Ozone to Produce Carbonyl Compounds • Alkyl Halide Occurrence • Alkylation of Aldehydes or Ketones • Alkylation of an Alkynyl Anion • Amides Can Be Converted into Aldehydes • An Alkane are Prepared from an Haloalkane • Barbier Coupling Reaction • Baylis-Hillman Reaction • Bucherer-Bergs Reaction • Chloroalkane Synthesis with SOCI2 • Clemmensen Reduction • Complex Metal Hydride Reductions • Conjugated Enone Takes Part in 1,4-Additions • Convert Aldonic Acid into the Lower Aldose by Oxidative Decarboxylation • Convert Esters into Aldehydes Using a Milder Reducing Agent • Convert Haloalkanes into Alcohols by SN2 • Corey-Chaykovsky Reaction • Corey-Fuchs Reaction • Cyanohydrins can be Convert to Carbonyl Compounds under Basic Conditions • Deoxygenation of the Carbonyl Group • Deprotonation of a Carbonyl Compound at the α -Carbon • DIBAL Attack Nitriles to Give Ketones • Dithioacetal Formation • Enamine Formation • Enamines Can Be Used to Prepare Alkylated Aldehydes • Enol-Keto Equilibration • Exclusive 1,4-Addition of a Lithium Organocuprate • Fischer Indole Synthesis • Friedel-Crafts Alkylation of Benzene with Haloalkanes • General Reactivity • Grignard Reaction • Halogenation of Alkenes • Hantzsch Dihydropyridine Synthesis • Hemiaminal Formation from Amines and Aldehydes or Ketones • Hemiaminal Formation from Amines and Aldehydes or Ketones • Henry Nitroaldol Reaction • HIO4 Oxidatively Degrades Vicinal Diols to Give Carbonyl Derivatives • Hiyama Cross-Coupling Reaction • Horner-Wadsworth-Emmons Reaction • Hydration of the Carbonyl Group • Hydride Reductions • Hydride Reductions of Aldehydes and Ketones to Alcohols • Hydride Reductions of Aldehydes and Ketones to Alcohols • Hydroboration of a Terminal Alkyne • Hydrogenation by Palladium on Carbon Gives the Saturated Carbonyl Compound • Hydrolysis of Imines to Aldehydes and Ketones • Imine Formation from Amines and Aldehydes or Ketones • Julia-Kocienski Olefination • Kinetics of Alkyl Halides • Knoevenagel Condensation • Kumada Cross-Coupling Reaction • Leuckart-Wallach Reaction • Lithium Organocuprate may Add to the α ,β -Unsaturated Carbonyl Function in 1,4-Fashion • McMurry Coupling • Meerwein-Ponndorf-Verley Reduction • Methylation of Ammonia • Mukaiyama Aldol Reaction • Nozaki-Hiyama-Kishi Reaction • Oxidation of Alcohols to Carbonyl Compounds • Oxidation of Aldehydes Furnishes Carboxylic Acids • Passerini Reaction • Paternò-Büchi Reaction • Periodic Acid Degradation of Sugars • Petasis Reaction • Phenylhydrazone and Phenylosazone Formation • Pictet-Spengler Tetrahydroisoquinoline Synthesis • Preparation of Aldehydes and Ketones • Preparation of Amines • Prins Reaction • Pyrroles, Furans, and Thiophenes are Prepared from γ-Dicarbonyl Compounds • Reactions of Aldehydes and Ketones • Reactions of Alkyl Halides with Reducing Metals • Reactions of Amines • Reduction of an Ester to an Aldehyde • Reductive Amination • Reformatsky Reaction • Schlosser Modification of the Wittig Reaction • Schmidt Reaction • Selective Eduction of Acyl Chlorides to Produce Aldehydes • Stetter Reaction • Stille Coupling • Stobbe Condensation • Strecker Synthesis • Substitution and Elimination Reactions of Alkyl Halides • Suzuki Coupling • Synthesis of 2-Amino Nitriles • Tebbe Olefination • The Cycloaddition of Dienes to Alkenes Gives Cyclohexenes • The Wittig Reaction • Thiazolium Salt Catalysis in Aldehyde Coupling • Thiazolium Salts Catalyze Aldehyde Coupling • Thiazolium Salts Catalyze Aldehyde Coupling • Ugi Reaction • Use 1,3-dithiane to Prepare of α-Hydroxyketones • Wittig Reaction • Wolff-Kishner Reduction
Historical Records

Related Functional Groups of
[ 50270-27-4 ]

Chlorides

Chemical Structure| 5305-40-8

[ 5305-40-8 ]

4,6-Dichloropyrimidine-5-carbaldehyde

Similarity: 0.93

Chemical Structure| 1780-36-5

[ 1780-36-5 ]

2,4,6-Trichloro-5-methylpyrimidine

Similarity: 0.88

Chemical Structure| 14160-91-9

[ 14160-91-9 ]

4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde

Similarity: 0.84

Chemical Structure| 5604-46-6

[ 5604-46-6 ]

2-Amino-4,6-dichloropyrimidine-5-carbaldehyde

Similarity: 0.84

Chemical Structure| 60025-06-1

[ 60025-06-1 ]

1-(4,6-Dichloropyrimidin-5-yl)ethanone

Similarity: 0.82

Aldehydes

Chemical Structure| 5305-40-8

[ 5305-40-8 ]

4,6-Dichloropyrimidine-5-carbaldehyde

Similarity: 0.93

Chemical Structure| 14160-91-9

[ 14160-91-9 ]

4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde

Similarity: 0.84

Chemical Structure| 5604-46-6

[ 5604-46-6 ]

2-Amino-4,6-dichloropyrimidine-5-carbaldehyde

Similarity: 0.84

Chemical Structure| 16019-33-3

[ 16019-33-3 ]

2-(4,6-Dichloropyrimidin-5-yl)acetaldehyde

Similarity: 0.76

Chemical Structure| 33097-11-9

[ 33097-11-9 ]

4,6-Dichloro-2-(methylthio)pyrimidine-5-carbaldehyde

Similarity: 0.73

Related Parent Nucleus of
[ 50270-27-4 ]

Pyrimidines

Chemical Structure| 5305-40-8

[ 5305-40-8 ]

4,6-Dichloropyrimidine-5-carbaldehyde

Similarity: 0.93

Chemical Structure| 1780-36-5

[ 1780-36-5 ]

2,4,6-Trichloro-5-methylpyrimidine

Similarity: 0.88

Chemical Structure| 14160-91-9

[ 14160-91-9 ]

4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde

Similarity: 0.84

Chemical Structure| 5604-46-6

[ 5604-46-6 ]

2-Amino-4,6-dichloropyrimidine-5-carbaldehyde

Similarity: 0.84

Chemical Structure| 60025-06-1

[ 60025-06-1 ]

1-(4,6-Dichloropyrimidin-5-yl)ethanone

Similarity: 0.82

; ;